Subscribe to Newsletter

Biochemistry and molecular biology

Diagnostics Biochemistry and molecular biology

Quick Hits

| Luke Turner

Read these bite-size breakthroughs to discover the latest research in the field of diagnostic medicine

Subspecialties Histology

Molecular Drivers of Mesothelioma

| Stefania Erra, Carolina Pelazza

A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options

Subspecialties Microbiology and immunology

A Whole New (Microbial) World

| Luke Turner

New research uncovers thousands of previously unidentified tiny proteins in the microbiome that could advance our understanding of human health

Subspecialties Cytology

A Better Future for Bladder Cancer

| John Cucci

A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer

Subspecialties Cytology

Protecting Patients from Progression

| Michael Schubert

A new molecular test offers the first opportunity to identify the patients who are most likely to benefit from treatment, rather than surveillance

Diagnostics Genetics and epigenetics

Exploring the Epi-signature

| Luke Turner

New research shows that genome-wide testing of DNA methylation can diagnose previously unsolved cases of neurodevelopmental and congenital anomalies

Diagnostics Genetics and epigenetics

A Day at the (sncRNA) Zoo

| Luke Turner

It’s tricky to distinguish between valid and false-positive miRNA biomarkers – but evolutionarily conserved genetic signatures in animals could help

Subspecialties Biochemistry and molecular biology

A Longer Life With Liver Cancer

| Luke Turner

Targeting a pathway that promotes cancer immune evasion could prolong immunotherapy and reduce its side effects for liver cancer patients

Inside the Lab Biochemistry and molecular biology

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

Diagnostics Biochemistry and molecular biology

IVF ID

| Jonathan James

A neural network called STORK can predict embryo quality with over 90 percent accuracy, offering fresh hope for successful in vitro fertilization.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register